Further analysis showed that 73.3% of colorectal cancer patients, 83.3% of gastric cancer patients, and 82.3% of lung cancer patients were distributed in the low level of serum ULBP3 (<15 ng/ml), as shown in Table 1. Here, ULBP3 is linked to colorectal cancer.